Merck

What do we know about new cholesterol drug Lipfendra? Merck’s new once-daily drug gets FDA approval

By WEB DESK TEAM

Comments Off on What do we know about new cholesterol drug Lipfendra? Merck’s new once-daily drug gets FDA approval

July 18, 2026

2 Min Read

The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily cholesterol-lowering drug developed by Merck & Co. Lipfendra, whose generic name is enlicitide, works by blocking a protein called PCSK9. This protein…